SIA "Regenpharma"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 12 000 € (41% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2018–2025
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||
| Total current assets | 3321 | 5 | 1 | 15 748 | 21 276 | 28 537 | 65 760 | 112 107 |
| Total non-current assets | 0 | 0 | 0 | 853 | 3537 | 13 903 | 13 856 | 14 983 |
| Total assets | 3321 | 5 | 1 | 16 601 | 24 813 | 42 440 | 79 616 | 127 090 |
| Balance sheet — liabilities and equity | ||||||||
| Current liabilities | 4304 | 4356 | 4407 | 40 839 | 76 065 | 91 060 | 50 695 | 36 217 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 4304 | 4356 | 4407 | 40 839 | 76 065 | 91 060 | 50 695 | 36 217 |
| Share capital | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — |
| Profit for the year | -986 | -3368 | -55 | -19 832 | -27 014 | 3005 | 77 541 | 73 952 |
| Total equity | -983 | -4351 | -4406 | -24 238 | -51 252 | -48 620 | 28 921 | 90 873 |
| Income statement | ||||||||
| Sales revenue | 8490 | 5120 | 0 | 28 228 | 260 086 | 318 799 | 418 500 | 458 467 |
| Operating profit | -986 | -3368 | -55 | -19 832 | -27 014 | 3005 | 77 541 | 76 952 |
| Profit before income tax | -986 | -3368 | -55 | -19 832 | -27 014 | 3005 | 77 541 | 76 952 |
| Profit for the reporting year | -986 | -3368 | -55 | -19 832 | -27 014 | 3005 | 77 541 | 73 952 |
| Labour costs | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||
| Employees | 1 | 1 | 1 | 5 | 8 | 7 | 5 | 6 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 12 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- žurnāls "MIRĀŽA"
- žurnāls "MIRAŽ"
- žurnāls "ŽURNĀLS DŽENTLMENIS"
- Sabiedrība ar ierobežotu atbildību "SINTEZ-WEST"
- Sabiedrība ar ierobežotu atbildību "Boons"
- "In Patria Credere"
- Sabiedrība ar ierobežotu atbildību "Creative4U"
- Baltic Power Reserve SIA
- SIA Balanss - V
- SIA Baltic General Power Company
- Sabiedrība ar ierobežotu atbildību "FREGO"
Summary: SIA "Regenpharma"
Overview
SIA "Regenpharma" (reg. no. 40203140672) is a limited liability company. The company was registered in 2018 and has been in the register for 8 years. Registered address: Rīga, Miesnieku iela 8.
Financial results
Revenue in 2025 was 458 467 €, up 9,6% on the previous year (418 500 €). From 2018 to 2025, revenue grew by an average of 76,8% per year. This is the company's highest revenue among the published years (2018–2025). Net profit for 2025 was 73 952 € (16,1% of revenue). The company was profitable in 3 of the 8 published years. In 2025 the company had 6 employees (5 a year earlier). Revenue per employee was 76 411 €. At the end of 2025, total assets were 127 090 € and equity 90 873 € (71,5% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.